Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial – JAMA Editorial: Influenza Vaccine for Patients With High-risk Cardiovascular Disease Commentary: High-dose influenza vaccine shows no additional benefit for heart disease patients – NIH News Releases   Commentary on Twitter […]

The post Randomized trial: High-dose influenza vaccine shows no additional benefit for heart disease patients appeared first on Links Medicus.